CN113142579A - Method for preparing cinnamon extraction powder and cinnamon extraction powder - Google Patents
Method for preparing cinnamon extraction powder and cinnamon extraction powder Download PDFInfo
- Publication number
- CN113142579A CN113142579A CN202010075605.2A CN202010075605A CN113142579A CN 113142579 A CN113142579 A CN 113142579A CN 202010075605 A CN202010075605 A CN 202010075605A CN 113142579 A CN113142579 A CN 113142579A
- Authority
- CN
- China
- Prior art keywords
- cinnamon
- cinnamon extract
- extract powder
- powder
- mincing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 71
- 241000723347 Cinnamomum Species 0.000 title claims abstract description 39
- 235000017803 cinnamon Nutrition 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000000605 extraction Methods 0.000 title description 4
- 235000020230 cinnamon extract Nutrition 0.000 claims abstract description 83
- 230000001954 sterilising effect Effects 0.000 claims abstract description 22
- 238000001914 filtration Methods 0.000 claims abstract description 20
- 239000007864 aqueous solution Substances 0.000 claims abstract description 16
- 239000011259 mixed solution Substances 0.000 claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 238000004108 freeze drying Methods 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims description 16
- 238000004659 sterilization and disinfection Methods 0.000 claims description 14
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 claims description 11
- 235000011987 flavanols Nutrition 0.000 claims description 11
- 235000008777 kaempferol Nutrition 0.000 claims description 11
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempherol Natural products C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims description 11
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 10
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims description 10
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 10
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 10
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims description 10
- 230000010355 oscillation Effects 0.000 claims description 10
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 10
- 235000005493 rutin Nutrition 0.000 claims description 10
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 10
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims description 10
- 229960004555 rutoside Drugs 0.000 claims description 10
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 claims description 9
- 229930182470 glycoside Natural products 0.000 claims description 9
- -1 kaempferol glycosides Chemical class 0.000 claims description 9
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 claims description 8
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 claims description 8
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 claims description 8
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 claims description 8
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 3
- 238000001223 reverse osmosis Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 6
- 229940117916 cinnamic aldehyde Drugs 0.000 description 6
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 244000037364 Cinnamomum aromaticum Species 0.000 description 4
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 4
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229940093797 bioflavonoids Drugs 0.000 description 4
- 239000013065 commercial product Substances 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 150000002206 flavan-3-ols Chemical class 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 3
- 230000002633 protecting effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- OVSQVDMCBVZWGM-LQSBFMDOSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-LQSBFMDOSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000917739 Cinnamomum wilsonii Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/11—Natural spices, flavouring agents or condiments; Extracts thereof obtained by solvent extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0261—Solvent extraction of solids comprising vibrating mechanisms, e.g. mechanical, acoustical
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/0003—Compounds of unspecified constitution defined by the chemical reaction for their preparation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Acoustics & Sound (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Mechanical Engineering (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method for preparing cinnamon extract powder and the cinnamon extract powder, the method comprises: (a) mixing a plurality of cinnamon branches and leaves with the aqueous solution, putting the mixture into a mincing device, and mincing the cinnamon branches and leaves by using the mincing device to form a mixed solution; (b) placing the mixed solution into an oscillating device, and oscillating the mixed solution by using the oscillating device; (c) filtering the mixed solution by using a filtering device to form a cinnamon filtering liquid; (d) sterilizing the cinnamon filtered liquid by using a sterilizing device to form cinnamon extract; (e) freeze-drying the cinnamon extract by using a freeze dryer to form a blocky cinnamon extract; (f) the cinnamon extract is ground into a powder form to form a plurality of cinnamon extract powders.
Description
Technical Field
The invention relates to a method and a product thereof, in particular to a method for preparing cinnamon extract powder and the cinnamon extract powder.
Background
With the prevalence of wind and qi in modern health preservation, more and more people pay attention to the intake of nutrients. The cinnamon leaves or cinnamon substitute, such as cinnamon bark, which has a plurality of nutrients and can be used for medical treatment, seasoning, aroma, medicinal materials and the like, is gradually utilized. The raw leaves of cinnamon or cinnamomum cassia (hereinafter, referred to as cinnamomum cassia raw leaves) contain cinnamaldehyde (cinnamaldehyde), and cinnamaldehyde has the most extensive use and the highest use value. Research shows that the cinnamaldehyde has the effects of reducing the concentration of uric acid in blood, stabilizing blood sugar, strengthening insulin, quickly permeating, strengthening bactericidal power, inhibiting dermatophytes, generating no drug resistance, preventing insects, resisting bacteria, resisting inflammation and the like. In addition, according to research, the cinnamaldehyde also has the effects of resisting oxidation, inhibiting liver cancer, protecting liver, reducing blood fat and the like. In addition, the cinnamon raw leaves also contain nutrient components such as cinnamyl acetate, rutin, kaempferol glycoside, flavanol, isoquercitin, etc.
However, even though the tea leaves of Cinnamomum wilsonii Hance prepared by pulverizing branches and leaves of 100% original Cinnamomum cassia leaves are analyzed by the present inventors, the cinnamaldehyde content is only about 1mg/g, cinnamyl acetate is only 0.027mg/g, kaempferol glycoside is only 0.042mg/g, isoquercitrin is only 0.021mg/g, and flavanol and rutin are not analyzed because of their lower than standard amount. Therefore, there is room for improvement in the prior art cinnamon products and methods for making the same.
Disclosure of Invention
In view of the problems of the prior art, such as low content of bioflavonoids. A primary object of the present invention is to provide a method for producing cinnamon extract powder, which solves at least one problem of the prior art.
The invention aims to solve the problems of the prior art, and adopts a necessary technical means to provide a method for preparing cinnamon extract powder, which comprises the following steps: (a) mixing a plurality of cinnamon branches and leaves with an aqueous solution, putting the mixture into a mincing device, and mincing the cinnamon branches and leaves by using the mincing device within a mincing time to form a mixed solution, wherein the mixed solution contains a plurality of cinnamon branch and leaf scraps; (b) placing the mixed solution into an oscillation device, and oscillating the mixed solution at an oscillation frequency within an oscillation time by using the oscillation device; (c) filtering the oscillated mixed solution by using a filtering device to remove cinnamon branch and leaf debris to form cinnamon filtering liquid; (d) sterilizing the cinnamon filtering liquid by using a sterilizing device at a sterilizing temperature within a sterilizing time so as to form cinnamon extract; (e) freeze-drying the cinnamon extract by using a freeze dryer to form a blocky cinnamon extract; and (f) grinding the lumpy cinnamon extract into a powder, thereby forming a plurality of cinnamon extract powders.
Based on the above-mentioned necessary technical means, an accessory technical means derived from the present invention is to make the weight ratio of the aqueous solution to the branches and leaves of cinnamon in the manufacturing method of cinnamon extract powder between 1: 0.5 to 1: 3.
based on the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to maintain the temperature of an aqueous solution of the aqueous solution in the manufacturing method of cinnamon extract powder at 60 to 90 ℃.
Based on the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to make the aqueous solution in the manufacturing method of cinnamon extract powder be RO reverse osmosis water.
Based on the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to make the mincing time in the method for producing cinnamon extract powder be between 2 and 30 minutes.
Based on the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to make the oscillation frequency in the method for preparing cinnamon extract powder between 1 to 2000000 hz.
Based on the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to make the oscillation time in the manufacturing method of cinnamon extract powder be between 0.5 and 2 hours.
Based on the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to make the filtering device in the manufacturing method of cinnamon extract powder be a filter screen, and the mesh of the filter screen is between 10 and 500 meshes.
Based on the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to make the filtering device in the method for producing cinnamon extract powder be a centrifugal filter.
Based on the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to make the sterilization time in the manufacturing method of cinnamon extract powder be between 3 to 20 minutes.
Based on the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to maintain the sterilization temperature in the manufacturing method of cinnamon extract powder between 100 to 250 ℃.
The present invention is to solve the problems of the prior art, and the necessary technical means is to provide a cinnamon extract powder, which is prepared by the method for preparing the cinnamon extract powder, and at least comprises cinnamyl acetate, wherein the cinnamyl acetate accounts for 0.08106 to 0.15054 wt% of the cinnamon extract powder.
Based on the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to make the cinnamon extract powder further contain rutin, wherein the rutin accounts for 0.06013-0.11167 wt% of the cinnamon extract powder.
Based on the above-mentioned necessary technical means, an accessory technical means derived from the present invention is that the cinnamon extract powder further comprises a kaempferol glycoside, wherein the kaempferol glycoside accounts for 0.8435-1.5665 wt% of the cinnamon extract powder.
Based on the above-mentioned necessary technical means, an accessory technical means derived from the present invention is that the cinnamon extract powder further comprises a flavanol, and the flavanol accounts for 0.28196-0.52364 wt% of the cinnamon extract powder.
Based on the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to make the cinnamon extract powder further contain isoquercetin, and the isoquercetin accounts for 0.68922-1.27998 wt% of the cinnamon extract powder.
In summary, the cinnamon extracted powder produced by the method of the present invention contains much higher content of nutrients than the cinnamon extracted powder produced by the prior art after experimental analysis.
Drawings
Fig. 1 is a flow chart of a method for producing cinnamon extract powder according to a preferred embodiment of the present invention.
Detailed Description
Embodiments of the present invention will be described in more detail below with reference to the accompanying drawings. Advantages and features of the present invention will become apparent from the following description and claims. It is to be noted that the drawings are in a very simplified form and are provided solely for the purpose of facilitating and distinctly facilitating the description of the embodiments of the present invention.
Referring to fig. 1, fig. 1 is a flow chart illustrating a method for manufacturing cinnamon extract powder according to a preferred embodiment of the present invention. As shown in fig. 1, a method for manufacturing cinnamon extract powder includes the following steps S101 to S107.
Step S101: mixing the branches and leaves of Cinnamomum cassia with an aqueous solution, and mincing in a mincing device.
The weight ratio of the cinnamon branches and leaves to the aqueous solution is 1: 0.5 to 1: 3, or less. In this example, the weight ratio is 1: 1.
the aqueous solution can be RO reverse osmosis water, electrolytic water, mineral water, distilled water, deep seawater or other aqueous solution. The temperature of the aqueous solution is 60 to 90 ℃, and in this embodiment, the temperature of the aqueous solution is 70 ℃.
Step S102: mincing the cinnamon branches and leaves by using a mincing device within a mincing time to form a mixed liquid containing a plurality of cinnamon branch and leaf scraps.
In this example, the mincing time is 5 minutes, but not limited thereto. The mincing time can be between 2 and 30 minutes, depending on the number of cinnamon branches and leaves.
Step S103: the mixed liquid is put into an oscillating device, and the oscillating device is utilized to oscillate the mixed liquid at an oscillating frequency within an oscillating time.
The oscillation device may be an ultrasonic oscillator. The oscillation frequency is between 1 and 2000000 Hz. In this embodiment, the oscillation frequency is an ultrasonic frequency between 20000 to 2000000 hz. The shaking time was between 0.5 and 2 hours, in this example 1 hour.
Step S104: and filtering the mixed liquid oscillated by the oscillating device by using a filtering device to remove the cinnamon branch and leaf fragments to form cinnamon filtering liquid.
The filtering device can use a filter screen mode or a centrifugal mode for filtering. In this embodiment, the filtering device is a filter, and the mesh of the filter is 150 meshes. In other embodiments of the present invention, the mesh of the filter screen may be from 10 to 500 mesh.
Step S105: sterilizing the cinnamon filtering liquid at a sterilization temperature within a sterilization time by using a sterilization device to form a cinnamon extract.
In the present embodiment, the sterilization temperature is 100 ℃ and the sterilization time is 5 minutes, but not limited thereto. The sterilization temperature may be between 100 and 300 ℃ and the sterilization time may be between 5 and 30 minutes.
Step S106: freeze-drying the cinnamon extract by a freeze dryer to form a lumpy cinnamon extract.
The freeze dryer is a well-known technology in the technical field, and can remove 95 to 99 percent of water, so that the cinnamon extract becomes blocky cinnamon extract and can keep the nutritional ingredients of the blocky cinnamon extract. Since moisture is removed, the cinnamon extract cake can be preserved for a long period of time without deterioration.
Step S107: the cinnamon extract is ground into a powder form to form a plurality of cinnamon extract powders.
Since the cinnamon extract cake can be preserved for a long period of time without deterioration, but the storage and use of the cake is inconvenient, the cinnamon extract cake is ground into cinnamon extract powder to improve the convenience of storage and use. It should be noted that the plurality of cinnamon extract powders actually means a plurality of cinnamon extract powder particles.
The present inventors performed High Performance Liquid Chromatography (HPLC) analysis on the cinnamon extract powder prepared by the method for manufacturing cinnamon extract powder according to the preferred embodiment of the present invention, and the results of the analysis are listed in the following table i, wherein the commercially available cinnamon product (wenbergli cinnamon tea) is also regarded as the prior art.
| Commercially available product | Cinnamon extract powder | |
| Acetic acid cinnamyl ester | 0.027mg/g | 1.158mg/g |
| Rutin (Cycleic acid) | - | 0.859mg/g |
| Kaempferol glycoside | 0.042mg/g | 12.050mg/g |
| Flavanols | - | 4.028mg/g |
| Isoquercitrin | 0.021mg/g | 9.846mg/g |
Watch 1
Regarding the content of cinnamyl acetate, 1.158mg/g of cinnamon extract powder is greater than 0.027mg/g of commercial product. The cinnamyl acetate can prevent excessive mucus and spasm, and has effects of strongly diminishing inflammation and improving sleep.
Regarding the rutin content, 0.859mg/g of cinnamon extract powder is greater than the commercial product that cannot be detected. Rutin is a component of bioflavonoids, has the effects of strengthening capillaries, treating bruise, treating varicosity, treating hemorrhoids, resisting inflammation and the like, and has obvious curative effects on retinal hemorrhage, capillary apoplexy, coronary artery obstruction and gingival hemorrhage.
With respect to the kaempferol glycoside content, 12.050mg/g of cinnamon extract powder is greater than 0.042mg/g of the commercial product. According to partial pathological studies kaempferols have been demonstrated to have a broad range of pharmacological activities, such as: antioxidant, antiinflammatory, antibacterial, anticancer, antianxiety, antiallergic, analgesic, nerve protecting, and heart protecting effects. In addition, the incidence of lung cancer can be reduced by the ingestion of kaempferol.
Regarding the flavanol content, 4.028mg/g of cinnamon extract powder is greater than the commercial product that could not be detected. Flavanols are also a component of bioflavonoids, have antioxidant effects, are helpful for lowering blood pressure, and are beneficial for cardiovascular health. In addition, it has been shown that flavanols reduce cognitive disability caused by some degree of aging.
With respect to the content of isoquercetin, 9.846mg/g of cinnamon extract powder is greater than 0.021mg/g of that of the commercially available product. Isoquercitrin is also a component of bioflavonoids, and has effects of resisting oxidation and inhibiting cancer pathological changes.
In summary, the experimental analysis of the cinnamon extract powder produced by the method for producing cinnamon extract powder provided by the invention proves that the cinnamon acetate contained in each gram of cinnamon extract powder is at least 40 times (including) that of the cinnamon extract powder in the prior art, and the rutin, kaempferol glycoside, flavanol and isoquercitin are all higher than those in the prior art. Therefore, compared with the prior art, the invention can retain more nutrient components and has higher nutritive value.
The foregoing detailed description of the preferred embodiments is intended to more clearly illustrate the features and spirit of the present invention, and not to limit the scope of the invention by the preferred embodiments disclosed above. On the contrary, it is intended to cover various modifications and equivalent arrangements included within the scope of the claims appended hereto.
Claims (16)
1. A method for preparing cinnamon extract powder is characterized by comprising the following steps:
(a) mixing a plurality of cinnamon branches and leaves with an aqueous solution, putting the mixture into a mincing device, and mincing the cinnamon branches and leaves by using the mincing device within the mincing time to form a mixed solution, wherein the mixed solution contains a plurality of cinnamon branch and leaf fragments;
(b) putting the mixed solution into an oscillating device, and oscillating the mixed solution at an oscillating frequency within an oscillating time by using the oscillating device;
(c) filtering the oscillated mixed solution by using a filtering device to remove the plurality of cinnamon branch and leaf fragments to form cinnamon filtering liquid;
(d) sterilizing the cinnamon filtered liquid at a sterilization temperature within a sterilization time by using a sterilization device to form cinnamon extract;
(e) freeze-drying the cinnamon extract by using a freeze dryer to form a blocky cinnamon extract; and
(f) grinding the lumpy cinnamon extract into a powder, thereby forming a plurality of cinnamon extract powders.
2. The method of claim 1, wherein the weight ratio of the aqueous solution to the plurality of cinnamon branches and leaves is between 1: 0.5 to 1: 3.
3. the method of claim 1, wherein the aqueous solution has a temperature of 60 to 90 ℃.
4. The method of manufacturing cinnamon extract powder according to claim 1, wherein said aqueous solution is RO reverse osmosis water.
5. The method of claim 1, wherein the mincing time is between 2 and 30 minutes.
6. The method of claim 1, wherein the oscillation frequency is between 1 to 2000000 Hz.
7. The method of claim 1, wherein the shaking time is between 0.5 and 2 hours.
8. The method of claim 1, wherein the filtering device is a screen, and the mesh of the screen is 10-500 mesh.
9. The method of claim 1, wherein the filter device is a centrifugal filter.
10. The method of claim 1, wherein the sterilization time is between 3 and 20 minutes.
11. The method of claim 1, wherein the sterilization temperature is between 100 and 250 ℃.
12. The cinnamon extract powder, which is prepared by the method of claim 1, comprising at least cinnamyl acetate, wherein the cinnamyl acetate accounts for 0.08106-0.15054 wt% of the cinnamon extract powder.
13. The cinnamon extract powder of claim 12, further comprising rutin, wherein the rutin comprises 0.06013 to 0.11167 wt% of the cinnamon extract powder.
14. The cinnamon extract powder of claim 12, further comprising kaempferol glycosides, wherein the kaempferol glycosides comprise 0.8435 to 1.5665 wt% of the cinnamon extract powder.
15. The cinnamon extract powder of claim 12, further comprising a flavanol, wherein the flavanol comprises 0.28196 to 0.52364 wt% of the cinnamon extract powder.
16. The cinnamon extract powder of claim 12, further comprising isoquercetin, and wherein the isoquercetin comprises 0.68922 to 1.27998 wt% of the cinnamon extract powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010075605.2A CN113142579A (en) | 2020-01-22 | 2020-01-22 | Method for preparing cinnamon extraction powder and cinnamon extraction powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010075605.2A CN113142579A (en) | 2020-01-22 | 2020-01-22 | Method for preparing cinnamon extraction powder and cinnamon extraction powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113142579A true CN113142579A (en) | 2021-07-23 |
Family
ID=76881836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010075605.2A Pending CN113142579A (en) | 2020-01-22 | 2020-01-22 | Method for preparing cinnamon extraction powder and cinnamon extraction powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113142579A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1839939A (en) * | 2006-01-12 | 2006-10-04 | 上海大学 | Method for extracting alpha- glucosidase inhibitor from traditional Chinese cinnamomum cassia |
| TW201515656A (en) * | 2013-10-31 | 2015-05-01 | Derlin Biotech Corp | Extraction method of cinnamon aqueous extract used for inhibiting tyrosinase and composition containing the cinnamon aqueous extract |
| TWI672137B (en) * | 2018-06-27 | 2019-09-21 | 鼎赫生物科技股份有限公司 | Method for preparing anti-oxidation component kaempferol by hydrolysis technique in Taiwan native clay |
-
2020
- 2020-01-22 CN CN202010075605.2A patent/CN113142579A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1839939A (en) * | 2006-01-12 | 2006-10-04 | 上海大学 | Method for extracting alpha- glucosidase inhibitor from traditional Chinese cinnamomum cassia |
| TW201515656A (en) * | 2013-10-31 | 2015-05-01 | Derlin Biotech Corp | Extraction method of cinnamon aqueous extract used for inhibiting tyrosinase and composition containing the cinnamon aqueous extract |
| TWI672137B (en) * | 2018-06-27 | 2019-09-21 | 鼎赫生物科技股份有限公司 | Method for preparing anti-oxidation component kaempferol by hydrolysis technique in Taiwan native clay |
Non-Patent Citations (2)
| Title |
|---|
| 李健等: "肉桂总皂苷提取工艺的研究", 《天然产物研究与开发》 * |
| 黎贵卿等: "肉桂水溶性多糖提取工艺的研究", 《化工技术与开发》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101620095B1 (en) | Manufacturing method of black curcuma and extract and powder thereof | |
| KR20220013451A (en) | Fermented Noni Vinegar Comprising Lactic Acid Bacteria Fermented Noni and Coconut Sugar and Method for Preparing Lactic Acid Bacteria Fermented Noni | |
| KR101670649B1 (en) | A method for preparation of mixed composition with fermented medical plants extracts | |
| CN104256661B (en) | A kind of fruit slice and preparation method thereof | |
| KR20180119772A (en) | Method for preparing extract of nipa fruticans and nipa fruticans extract thereby | |
| KR20160045347A (en) | Agent for Masking Bitterness of Ginseng and Ginseng Composition Containing the Same | |
| KR100894636B1 (en) | A manufacturing process of the beverage including yam extract | |
| CN113142579A (en) | Method for preparing cinnamon extraction powder and cinnamon extraction powder | |
| KR101403526B1 (en) | method for making cooked rice with lotus leaf or Phyllostachys nigra and cooked rice thereby | |
| CN105361055A (en) | Pickled vegetable nitrite content reducing method | |
| KR20160063080A (en) | Method of Manufacturing Aronia Juice and Aronia Concentrate, and Aronia Juice and Aronia Concentrate Manufactured by the same Method | |
| KR102267942B1 (en) | Antibacterial sauce and method of manufacturing the same | |
| JP3762364B2 (en) | Health food production method using earthworms and ants | |
| TW202128204A (en) | Method of manufacturing cinnamomum osmophloeum kaneh extraction powder and the cinnamomum osmophloeum kaneh extraction powder | |
| KR101509909B1 (en) | Sikhye comprising the extracts of achyranthes radix and manufacturing methods thereof | |
| KR101346567B1 (en) | Mixed fermented liquid of green tea flowers and pomegranates and its manufacturing method | |
| KR20110082682A (en) | Beverage for relieving hangover contained gracilaria verrucosa papenfuss and the manufacturing method thereof | |
| KR100668429B1 (en) | A manufacturing method of apple vinegar that contain saponin | |
| KR102191475B1 (en) | Noni syrup and manufacturing method thereof | |
| KR100378830B1 (en) | Method of making hangover solution drink | |
| JP3950848B2 (en) | Method for producing health food containing seri | |
| KR20200049228A (en) | Manufacturing method of ginseng-brown rice vinegar | |
| KR102219735B1 (en) | Manufacturing method for jam using andong yam and jam manufactured by the same | |
| KR20110024676A (en) | An arrowroot juice separated from starch and manufacturing method thereof | |
| KR102436544B1 (en) | Sugar-free candy manufacturing method using onion extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210723 |